decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 7 (July)
New model opioid policy addresses undertreatment of pain
Subscribe or sign in to view the full article.
Article Overview
This article explains a revised model policy for controlled-substance prescribing in pain management and why it matters to physicians concerned about regulatory scrutiny. It discusses general compliance themes such as documentation, patient monitoring, written agreements, and the importance of checking state-specific requirements. The piece is aimed at pain physicians, compliance staff, and coding/billing professionals who support practices that prescribe controlled substances.
Why This Topic Matters
The article helps readers understand the broader policy environment around pain treatment and controlled-substance prescribing. It is relevant to practices that want to align documentation and office procedures with current expectations from medical boards and enforcement agencies.
Article Sections
-
Model policy update and purpose
Introduces the revised federal-state model policy and explains its role in shaping pain-management oversight. Covers the general intent of the guidance and the organizations involved.
-
Practice compliance guidance for pain management
Describes broad documentation and monitoring themes discussed in the article, along with general practice-management concerns for physicians who treat pain. Focuses on compliance-oriented subjects rather than specific coding or treatment details.
-
State regulations and resource references
Notes the importance of reviewing state-specific prescribing requirements and mentions resource links provided in the article. Addresses where readers can look for additional policy information.
-
Red flags: physician habits DEA considers suspicious
Summarizes the article’s closing discussion of general behaviors that may draw regulatory attention. The section frames these as oversight concerns for pain practices.
What You Will Learn
- How a revised model policy is positioned for pain-management practices
- Why documentation and monitoring are emphasized in controlled-substance oversight
- How state-specific prescribing rules fit into broader compliance planning
- What types of physician behaviors may attract regulatory attention in pain practices
Who Should Read This
- Pain physicians
- Practice managers
- Compliance staff
- Medical office administrators
- Coding and billing professionals supporting pain management
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com